Dr. Tony Holohan:

There were actions at both levels. At the policy and legislative level, actions continued in terms of informing and prioritising the legislative effort, which is what I spoke about in my opening statement, that is, on supporting voluntary disclosure, creating the safe space and making disclosure more likely and setting standards for the disclosure that clinicians would do the right thing and support patients through that journey, while ultimately leading to the mandatory disclosure I spoke about briefly earlier.